Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ribozyme's anticancer drug Angiozyme shows promise in preclinical trials

May 7, 1998

Genset announces discovery of novel prostate cancer-related gene

May 7, 1998

Anticancer activity of mEGP has been reported

May 7, 1998

BE-56980: new antitumor agent discovered by Banyu

May 6, 1998

Apoptosis-inducing iminodiacetic acid derivatives described by Mitsui Toatsu

May 6, 1998

GenVec, Fuso collaborate on cancer gene therapies

May 6, 1998

FDA approves SuperGen's injectable mitomycin

May 6, 1998

New antitumor compounds from Ajinomoto

May 6, 1998

GenVec in-licenses rights to TNF-alpha for gene therapy applications

May 5, 1998

Phase I trial results presented for the antifolate LY-231514

May 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.